Oct. 2, 2012
It is not surprising to learn that Big Pharma has shown no interest in what may become the world’s first proven cancer prevention pill. If big profits aren’t promised, pharmaceutical companies predictably pass on such a development.
The pill is a relatively safe FDA-approved generic drug, prescribed millions of times to help control diabetes, and it costs maybe 10-cents a day. But what is surprising is that public health authorities appear to be remiss in announcing this breakthrough. They are the agency in society commissioned to address important public health issues such as this.
Data has been accumulating for 5 years now showing metformin (Glucophage): http://packageinserts.bms.com/pi/pi_glucophage.pdf, an anti-diabetic drug, dramatically reduces the risk for cancer and prolongs life among patients who are battling cancer.